Arrowhead Pharmaceuticals ARWR Earnings Call Transcripts

NASDAQ ARWR
$49.00 -0.24 (-0.49%)
At close: Nov 10, 2026 · 4:00 PM EST
15 earnings calls on file for Arrowhead Pharmaceuticals, from Q1 2020 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

Arrowhead Pharmaceuticals Q2 2026 Earnings Call

May 7, 2026 7,869 words · 34 min read
  • Dr. Christopher AnzaloneChief Executive Officer
  • Andy DavisChief Commercial Officer
  • Dr. James M. HamiltonChief Medical Officer
  • Daniel ApelChief Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Arrowhead Pharmaceuticals Earnings Call Transcripts

Calls15
LatestMay 7, 2026
SinceQ1 2020

Fiscal 2026

Fiscal 2025

Fiscal 2022

Fiscal 2021

Fiscal 2020

All 15 Arrowhead Pharmaceuticals transcripts Register to get access to Arrowhead Pharmaceuticals’s earnings call transcripts.